Original Research

Published on 20 May 2024

Natural compound Alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death

in Pharmacology of Anti-Cancer Drugs

Wang Liu
Chenchen He
Changlin Li
Shazhou Ye
Jiang Zhao
Cunle Zhu
Xiangwei Wang
Qi Ma
Benyi Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397116

1,344 views

Review

Published on 20 May 2024

Better together: nanoscale co-delivery systems of therapeutic agents for high-performance cancer therapy

in Pharmacology of Anti-Cancer Drugs

Liyan Sun
Zhe Li
Jinshuai Lan
Ya Wu
Tong Zhang
Yue Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389922

1,203 views

Original Research

Published on 20 May 2024

Enhanced amphiregulin exposure promotes modulation of the high grade serous ovarian cancer tumor immune microenvironment

in Pharmacology of Anti-Cancer Drugs

Jasmine Ebott
Julia McAdams
Chloe Kim
Corrine Jansen
Morgan Woodman
Payton De La Cruz
Christoph Schrol
Jennifer Ribeiro
Nicole James

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375421

1,598 views
2 citations

Case Report

Published on 20 May 2024

QL1604 combined with bevacizumab as an innovative first-line treatment for HCC patient with extensive metastasis who showed remarkable effect: a case report

in Pharmacology of Anti-Cancer Drugs

Yanzhi Wan
Keqin Tan
Hong Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364871

606 views

Systematic Review

Published on 17 May 2024

Efficacy and safety of FLT3 inhibitors in monotherapy of hematological and solid malignancies: a systemic analysis of clinical trials

in Pharmacology of Anti-Cancer Drugs

Yuying Zhao
Xuedi Zhang
Xiaoyan Ding
Ying Wang
Zhenpeng Li
Ronglan Zhao
Hai-En Cheng
Yanli Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1294668

2,036 views
1 citation

Original Research

Published on 16 May 2024

Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells

in Pharmacology of Anti-Cancer Drugs

Emily M. Esquea
Lorela Ciraku
Riley G. Young
Jessica Merzy
Alexandra N. Talarico
Nusaiba N. Ahmed
Mangalam Karuppiah
Anna Ramesh
Adam Chatoff
Claudia V. Crispim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1394685

3,232 views
1 citation

Original Research

Published on 16 May 2024

Identification and validation of a platelet-related signature for predicting survival and drug sensitivity in multiple myeloma

in Pharmacology of Anti-Cancer Drugs

Zhili Lin
Quanqiang Wang
Ziwei Zheng
Bingxin Zhang
Shujuan Zhou
Dong Zheng
Zixing Chen
Sisi Zheng
Shuxia Zhu
Xinyi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377370

1,352 views

Editorial

Published on 15 May 2024

Editorial: Novel therapeutic approach in cancer: the role of ion channels and transporters

in Pharmacology of Anti-Cancer Drugs

Concetta Altamura
Elena Lastraioli

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422127

497 views

Review

Published on 13 May 2024

A systematic review of the mechanism of action and potential medicinal value of codonopsis pilosula in diseases

in Pharmacology of Anti-Cancer Drugs

Huina Guo
YiChen Lou
Xiaofang Hou
Qi Han
Yujia Guo
Zhongxun Li
Xiaoya Guan
Hongliang Liu
Chunming Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1415147

1,777 views
2 citations

Systematic Review

Published on 10 May 2024

A comprehensive bibliometric analysis (2000–2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer

in Pharmacology of Anti-Cancer Drugs

Yuanqiong Duan
Lin Yang
Wenxiang Wang
Peixuan Zhang
Kaiyu Fu
Wen Li
Rutie Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1351363

2,033 views

Brief Research Report

Published on 10 May 2024

Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients

in Pharmacology of Anti-Cancer Drugs

Takeru Kashiwada
Ryotaro Takano
Fumihiko Ando
Shoko Kuroda
Yoshishige Miyabe
Ryuji Owada
Akihiko Miyanaga
Tomoko Asatsuma-Okumura
Masaaki Hashiguchi
Yoshikazu Kanazawa

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1384733

1,829 views
2 citations

Review

Published on 09 May 2024

Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds

in Pharmacology of Anti-Cancer Drugs

Qiuran Liang
Yuehui Wang
Yili Li
Jinyan Wang
Chuanbo Liu
Yicong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1374182

1,437 views
2 citations

Opinion

Published on 09 May 2024

Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup

in Pharmacology of Anti-Cancer Drugs

Jianghua Ding
Shengping Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1398879

871 views

Review

Published on 09 May 2024

Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer

in Pharmacology of Anti-Cancer Drugs

Feizhi Lin
Yongming Chen
Bowen Huang
Shenghang Ruan
Jun Lin
Zewei Chen
Chunyu Huang
Baiwei Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1391562

1,412 views
1 citation

Systematic Review

Published on 09 May 2024

Application and potential value of curcumin in prostate cancer: a meta-analysis based on animal models

in Pharmacology of Anti-Cancer Drugs

Shiheng Wang
Fengxia Zhang
Jing Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379389

1,235 views

Editorial

Published on 08 May 2024

Editorial: Targeting ion homeostasis for cancer therapy: mechanisms and immunomodulatory effects

in Pharmacology of Anti-Cancer Drugs

Xuemei Zeng
Zhenglin Li
Zhiyao Yi
Shuangqian Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418700

900 views

Navigation group

Articles

Natural compound Alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death

Better together: nanoscale co-delivery systems of therapeutic agents for high-performance cancer therapy

Enhanced amphiregulin exposure promotes modulation of the high grade serous ovarian cancer tumor immune microenvironment

QL1604 combined with bevacizumab as an innovative first-line treatment for HCC patient with extensive metastasis who showed remarkable effect: a case report

Efficacy and safety of FLT3 inhibitors in monotherapy of hematological and solid malignancies: a systemic analysis of clinical trials

Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells

Identification and validation of a platelet-related signature for predicting survival and drug sensitivity in multiple myeloma

Editorial: Novel therapeutic approach in cancer: the role of ion channels and transporters

A systematic review of the mechanism of action and potential medicinal value of codonopsis pilosula in diseases

A comprehensive bibliometric analysis (2000–2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer

Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients

Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds

Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup

Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer

Application and potential value of curcumin in prostate cancer: a meta-analysis based on animal models

Editorial: Targeting ion homeostasis for cancer therapy: mechanisms and immunomodulatory effects